189 related articles for article (PubMed ID: 1835892)
1. Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders.
Hoshino S; Oshimi K; Teramura M; Mizoguchi H
Blood; 1991 Dec; 78(12):3232-40. PubMed ID: 1835892
[TBL] [Abstract][Full Text] [Related]
2. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S
Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Facco M; Trentin L; Sancetta R; Tassinari C; Perin A; Milani A; Pizzolo G; Rodeghiero F; Agostini C; Meazza R; Ferrini S; Semenzato G
Blood; 1997 Jan; 89(1):201-11. PubMed ID: 8978293
[TBL] [Abstract][Full Text] [Related]
4. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
[TBL] [Abstract][Full Text] [Related]
5. Cell membrane expression and functional role of the p75 subunit of interleukin-2 receptor in lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Pizzolo G; Bulian P; Masciarelli M; Feruglio C; Agostini C; Raimondi R; Chisesi T; Semenzato G
Blood; 1990 Nov; 76(10):2080-5. PubMed ID: 2146981
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocyte triggering via CD16 is regulated by CD3 and CD8 antigens. Studies with T cell receptor (TCR)-alpha beta+/CD3+16+ and TCR-gamma delta+/CD3+16+ granular lymphocytes.
Oshimi K; Oshimi Y; Yamada O; Wada M; Hara T; Mizoguchi H
J Immunol; 1990 May; 144(9):3312-7. PubMed ID: 2139452
[TBL] [Abstract][Full Text] [Related]
7. Role of tumor necrosis factor-alpha and its specific 55-Kd and 75-Kd receptors in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Bulian P; Cassatella M; Raimondi R; Chisesi T; Agostini C; Semenzato G
Blood; 1992 Oct; 80(8):2030-7. PubMed ID: 1327287
[TBL] [Abstract][Full Text] [Related]
8. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
[TBL] [Abstract][Full Text] [Related]
9. Agonistic effects of anti-CD2 and anti-CD16 antibodies on human natural killer killing.
Uggla CK; Geisberg M; Jondal M; Knowles RW
Scand J Immunol; 1989 May; 29(5):507-15. PubMed ID: 2567053
[TBL] [Abstract][Full Text] [Related]
10. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
Heiskala M; Ståhls A; Seppälä I; Timonen T
Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
[TBL] [Abstract][Full Text] [Related]
11. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
[TBL] [Abstract][Full Text] [Related]
12. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
[TBL] [Abstract][Full Text] [Related]
13. IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Cassatella MA; Raimondi R; Cerutti A; Enthammer C; Facco M; Agostini C; Semenzato G
Br J Haematol; 1996 Feb; 92(2):308-14. PubMed ID: 8602990
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.
Zupo S; Azzoni L; Massara R; D'Amato A; Perussia B; Ferrarini M
J Clin Immunol; 1993 May; 13(3):228-36. PubMed ID: 7686565
[TBL] [Abstract][Full Text] [Related]
15. Patterns of CD16 and CD56 expression in persistent expansions of CD3+NKa+ lymphocytes are predictive for clonal T-cell receptor gene rearrangements. The Yorkshire Leukaemia Group.
Sivakumaran M; Richards SJ; Hunt KM; Steed AJ; Bynoe AG; Morgan MM; Pyrah R; Roberts BE; Scott CS
Br J Haematol; 1991 Jul; 78(3):368-77. PubMed ID: 1714758
[TBL] [Abstract][Full Text] [Related]
16. Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the zeta chain.
O'Shea JJ; Weissman AM; Kennedy IC; Ortaldo JR
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):350-4. PubMed ID: 1703295
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor-independent CD2 signal transduction in FcR+ cells.
Arulanandam AR; Koyasu S; Reinherz EL
J Exp Med; 1991 Apr; 173(4):859-68. PubMed ID: 1706751
[TBL] [Abstract][Full Text] [Related]
18. CD16- CD56+ natural killer cells after bone marrow transplantation.
Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE
Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S
Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
[TBL] [Abstract][Full Text] [Related]
20. Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Facco M; Siviero M; Galvan S; Piazza F; Perin A; Agostini C; Semenzato G
Blood; 2000 Jul; 96(2):647-54. PubMed ID: 10887130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
